Evidence map›Paper›PMID 35778407›Full record

ArticleNature communications2022

T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice.

Venetia Bazioti, Anouk M La Rose, Sjors Maassen, Frans Bianchi, Rinse de Boer, Benedek Halmos, Deepti Dabral, Emma Guilbaud, Arthur Flohr-Svendsen, Anouk G Groenen and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Loss of LXRβ Drives CD4Biomedicines · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Dysregulation of cholesterol homeostasis in cancer pathogenesis.Cellular and molecular life sciences : CMLS · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 4 countries.

Venetia BaziotiDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.ORCID 0000-0002-6076-5908
Anouk M La RoseDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.ORCID 0000-0002-9092-4316
Sjors MaassenDepartment of Molecular Immunology and Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747 AG, Groningen, the Netherlands.
Frans BianchiDepartment of Molecular Immunology and Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747 AG, Groningen, the Netherlands.ORCID 0000-0002-9385-9695
Rinse de BoerDepartment of Molecular Immunology and Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747 AG, Groningen, the Netherlands.
Benedek HalmosDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Deepti DabralDepartment of Molecular Immunology and Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747 AG, Groningen, the Netherlands.ORCID 0000-0002-0240-7125
Emma GuilbaudInstitut National de la Santé et de la Recherche Médicale (INSERM) U1065, Université Côte d'Azur, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, Fédération Hospitalo-Universitaire (FHU) Oncoage, 06204, Nice, France.
Arthur Flohr-SvendsenEuropean Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.ORCID 0000-0002-6224-2334
Anouk G GroenenDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.ORCID 0000-0002-2573-8701
Alejandro Marmolejo-GarzaDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Mirjam H KosterDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Niels J KloosterhuisDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Rick HavingaDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Alle T PrangerLaboratory of Medicine, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Miriam Langelaar-MakkinjeDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Alain de BruinDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.
Bart van de SluisDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands.ORCID 0000-0003-3039-4365
Alison B KohanDivision of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15260, USA.
Laurent Yvan-CharvetInstitut National de la Santé et de la Recherche Médicale (INSERM) U1065, Université Côte d'Azur, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, Fédération Hospitalo-Universitaire (FHU) Oncoage, 06204, Nice, France.ORCID 0000-0002-7748-4942
Geert van den BogaartDepartment of Molecular Immunology and Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, 9747 AG, Groningen, the Netherlands.ORCID 0000-0003-2180-6735
Marit WesterterpDepartment of Pediatrics, University Medical Center Groningen, University of Groningen, 9713 AV, Groningen, the Netherlands. m.westerterp@umcg.nl.ORCID 0000-0003-2230-1659
University Medical Center Groningen · NLUniversity of Groningen · NLInserm · FRUniversity of Pittsburgh · US

Funding

Determining the Role of apoC-III in the Immune SystemR01DK118239 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOHAN, ALISON BLOOM · 2019 to 2023
$2.3M
NIDDK NIH HHS R01 DK118239
6 · The paper itself

Abstract

Atherosclerosis is a chronic inflammatory disease driven by hypercholesterolemia. During aging, T cells accumulate cholesterol, potentially affecting inflammation. However, the effect of cholesterol efflux pathways mediated by ATP-binding cassette A1 and G1 (ABCA1/ABCG1) on T cell-dependent age-related inflammation and atherosclerosis remains poorly understood. In this study, we generate mice with T cell-specific Abca1/Abcg1-deficiency on the low-density-lipoprotein-receptor deficient (Ldlr

Indexed as

AtherosclerosisT-LymphocytesAnimalsApoptosisBiological TransportImmunologic Deficiency SyndromesInflammationMiceThymus Gland

Identifiers

PMID35778407
PMCPMC9249754
OpenAlexW4283743523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.